
|

| |
Track the *RXGEN Index |
 |
|
 | Generic Drug Stocks (*RXGEN) |
| |
Generic Drug Ideas |
|
|
|
Generic Drug Performance |
|
|
|
Generic Drug Community |
|
| |
|
Index Description: These firms have significant exposure to the generic side of the pharmaceutical industry, focusing on making generic versions of off-patent medications
|
|
|
|
|
Today:
1-month:
All-time:
|
-0.3%
+6.2%
+90.5%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
-0.2%
-1.0%
+69.8%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$24.9B
29.4
0.5%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| ACT |
$126.87 |
-0.28 |
-0.2% |
816,827 |
141% |
$16.2B |
- |
87% |
-3% |
3 Alerts (1 News) - View
|
|
|
| CPRX |
$0.89 |
+0.03 |
+2.9% |
119,478 |
32% |
$35.8M |
- |
141% |
-61% |
1 Alert (0 News) - View
|
|
|
| FRX |
$37.82 |
-0.16 |
-0.4% |
115,413 |
30% |
$10.1B |
- |
21% |
-3% |
3 Alerts (3 News) - View
|
|
|
| HITK |
$33.18 |
+0.23 |
+0.7% |
7,525 |
51% |
$446.9M |
- |
21% |
-13% |
No Alerts/News
|
|
|
| MNTA |
$12.82 |
-0.05 |
-0.4% |
60,744 |
68% |
$668.2M |
- |
28% |
-25% |
No Alerts/News
|
|
|
| MYL |
$31.14 |
-0.14 |
-0.5% |
788,091 |
47% |
$11.9B |
- |
52% |
-2% |
4 Alerts (2 News) - View
|
|
|
| NVS |
$73.92 |
-0.24 |
-0.3% |
282,687 |
65% |
$182.2B |
2.8% |
44% |
-2% |
1 Alert (0 News) - View
|
|
|
| PRGO |
$118.18 |
-0.85 |
-0.7% |
56,674 |
40% |
$11.1B |
0.3% |
20% |
-3% |
No Alerts/News
|
|
|
| RDY |
$36.73 |
-0.93 |
-2.5% |
73,231 |
101% |
$6.3B |
0.6% |
35% |
-5% |
No Alerts/News
|
|
|
| SGNT |
$16.95 |
+0.33 |
+2.0% |
13,642 |
66% |
$467.7M |
- |
34% |
-15% |
No Alerts/News
|
|
|
| TEVA |
$39.98 |
-0.21 |
-0.5% |
801,071 |
69% |
$34.2B |
2.4% |
9% |
-7% |
1 Alert (1 News) - View
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
Is There a Pill For That? Forest Labs’ Iffy Pipeline FRX JNJ AMGN PJC
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 21, 09:27AM from (ycharts.com) Forest Labs (FRX) has launched several new products in the past two years – yet has demonstrated limited success in filling
Flag
Post a comment
Teva Bets on Reformulating Old Drugs as Investors Say 'Show Me' BMY FRX LLY JNJ BIIB ALXA
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 21, 07:01AM from (www.bloomberg.com) Teva Pharmaceutical Industries Ltd. (TEVA), which just two years ago was analysts’ highest-rated stock among the world’s
Flag
Post a comment
Pharma M&A – Actavis to Acquire Warner Chilcott FRX MYL TEVA ACT VRX WCRX
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 20, 11:32AM from (www.benzinga.com) On Monday, generic drug maker Actavis Inc. (NYSE: ACT) announced plans to purchase specialty pharmaceutical company Warner
Flag
Post a comment
DealBook: Actavis to Buy Warner Chilcott in All-Stock Deal MYL VRX WCRX
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 20, 08:16AM from (dealbook.nytimes.com) Actavis, a maker of generic drugs, agreed to buy the specialty pharmaceutical company Warner Chilcott for about $5 billion
Flag
Post a comment
US Stocks Fluctuate on Manufacturing, Housing Reports AMD CSCO ACT TSLA
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 16, 10:37AM from (www.bloomberg.com) U.S. stock futures were little changed after the Standard & Poor’s 500 Index extended a record yesterday, and before
Flag
Post a comment
Teva US Jump Widens Holiday Discount: Israel Overnight TEVA ACT WCRX MLNX
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 15, 11:37PM from (www.bloomberg.com) Teva Pharmaceutical Industries Ltd. (TEVA) resumes trading today in Tel Aviv (TEVA) at the biggest discount to New York in
Flag
Post a comment
Sanofi Fined $52.8 Million for Denigrating Plavix Copies TEVA
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 14, 06:50AM from (www.bloomberg.com) Sanofi (SAN), France’s largest drugmaker, was fined 40.6 million euros ($52.8 million) by the country’s competition regulator
Flag
Post a comment
Dr. Reddy’s Q4 & FY13 Financial Results RDY
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 14, 06:08AM from (www.businesswire.com) Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its audited consolidated financial results for the fourth quarter
Flag
Post a comment
Israel Joins Rate Cut Club; ETF Doesn't Care And Falls TEVA EIS
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 13, 12:08PM from (www.benzinga.com) From Brussels to Sydney to Hanoi, global central banks have been taking the ax to interest rates over the past several weeks.
Flag
Post a comment
Market Wrap for Friday, May 10: Stocks Gain on Late Day Rally SPY ACT PANL CALL WCRX UUP TSLA MCP RH TLT
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 10, 04:15PM from (www.benzinga.com) It was another quiet day on Wall Street, but an afternoon rally pushed the U.S. stock market firmly into positive territory by the closing bell.
Flag
Post a comment
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences MNTA
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 09, 04:43PM from (globenewswire.com) CAMBRIDGE, Mass., May 9, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing
Flag
Post a comment
UBS Offers Global Dividend Ruler Stocks to Buy: Total, Teva, TD and More BNS UL TEVA TOT AZN PSO TD UBS SNY
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 09, 08:35AM from (247wallst.com) Total return is always the name of the game when it comes to investing success. Stocks that pay dividends on a regular basis
Flag
Post a comment
Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S. TEVA ALXA
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 08, 08:30AM from (www.businesswire.com) Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: TEVA), and Alexza Pharmaceuticals,
Flag
Post a comment
The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion ABT LLY JNJ AMGN TEVA AZN GSK
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 06, 10:45AM from (247wallst.com) The world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions
Flag
Post a comment
Sagent Pharmaceuticals Reports First Quarter 2013 Financial Results SGNT
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 06, 07:13AM from (globenewswire.com) SCHAUMBURG, Ill., May 6, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical
Flag
Post a comment
|
|
|